Myriad Genetics Receives Patent for High-Definition MRD Assay
The U.S. Patent and Trademark Office issued a patent to Myriad Genetics aimed at strengthening its ability to deliver a MRD assay to market.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
